Literature DB >> 22449867

Moderate influenza vaccine effectiveness in Victoria, Australia, 2011.

J E Fielding1, K A Grant, T Tran, H A Kelly.   

Abstract

We used a sentinel general practitioner (GP) network to conduct surveillance for laboratory-confirmed influenza amongst patients presenting with influenza-like illness (ILI) in Victoria, Australia in 2011. The test negative variation of the case control study design was used to estimate effectiveness for seasonal trivalent influenza vaccine. Cases and controls were ILI patients that tested positive and negative for influenza, respectively. Vaccination status was recorded by GPs and vaccine effectiveness (VE) was calculated as (1-adjusted odds ratio)x100%. There were 529 patients included in the study, of which 29% were influenza positive. Twelve percent of study participants were reported as vaccinated, 6% of cases and 15% of controls. Adjusted VE against all influenza was 56%, but not statistically significant. There was generally little variation in VE estimates when stratified by virus type and subtype, which is consistent with good matches between circulating strains and the vaccine strains. The VE was higher among adults of working age than among children.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22449867

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  17 in total

1.  Epidemiology of the 2012 influenza season in Victoria, Australia.

Authors:  James Fielding; Kristina Grant; Lucinda Franklin; Sheena Sullivan; Georgina Papadakis; Heath Kelly; Allen Cheng
Journal:  Western Pac Surveill Response J       Date:  2013-08-23

2.  Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates.

Authors:  Suzanne E Ohmit; Mark G Thompson; Joshua G Petrie; Swathi N Thaker; Michael L Jackson; Edward A Belongia; Richard K Zimmerman; Manjusha Gaglani; Lois Lamerato; Sarah M Spencer; Lisa Jackson; Jennifer K Meece; Mary Patricia Nowalk; Juhee Song; Marcus Zervos; Po-Yung Cheng; Charles R Rinaldo; Lydia Clipper; David K Shay; Pedro Piedra; Arnold S Monto
Journal:  Clin Infect Dis       Date:  2013-11-13       Impact factor: 9.079

3.  Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility.

Authors:  Suzanne E Ohmit; Joshua G Petrie; Ryan E Malosh; Alicia M Fry; Mark G Thompson; Arnold S Monto
Journal:  J Infect Dis       Date:  2014-11-21       Impact factor: 5.226

4.  Health and economic benefits of early vaccination and nonpharmaceutical interventions for a human influenza A (H7N9) pandemic: a modeling study.

Authors:  Nayer Khazeni; David W Hutton; Cassandra I F Collins; Alan M Garber; Douglas K Owens
Journal:  Ann Intern Med       Date:  2014-05-20       Impact factor: 25.391

5.  On the bias of estimates of influenza vaccine effectiveness from test-negative studies.

Authors:  Kylie E C Ainslie; Meng Shi; Michael Haber; Walter A Orenstein
Journal:  Vaccine       Date:  2017-11-13       Impact factor: 3.641

Review 6.  Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review.

Authors:  Sheena G Sullivan; Shuo Feng; Benjamin J Cowling
Journal:  Expert Rev Vaccines       Date:  2014-10-28       Impact factor: 5.217

7.  The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology.

Authors:  Huiying Chua; Shuo Feng; Joseph A Lewnard; Sheena G Sullivan; Christopher C Blyth; Marc Lipsitch; Benjamin J Cowling
Journal:  Epidemiology       Date:  2020-01       Impact factor: 4.822

8.  Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination.

Authors:  Silvia Jiménez-Jorge; Salvador de Mateo; Concha Delgado-Sanz; Francisco Pozo; Inmaculada Casas; Manuel Garcia-Cenoz; Jesús Castilla; Esteban Pérez; Virtudes Gallardo; Carolina Rodriguez; Tomás Vega; Carmen Quiñones; Eva Martínez; Juana María Vanrell; Jaume Giménez; Daniel Castrillejo; María del Carmen Serrano; Julián Mauro Ramos; Amparo Larrauri
Journal:  BMC Infect Dis       Date:  2013-09-22       Impact factor: 3.090

9.  Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014.

Authors:  S G Sullivan; K S Carville; M Chilver; J E Fielding; K A Grant; H Kelly; A Levy; N P Stocks; S S Tempone; A K Regan
Journal:  Epidemiol Infect       Date:  2016-04-29       Impact factor: 4.434

10.  Influenza vaccine effectiveness in the tropics: moderate protection in a case test-negative analysis of a hospital-based surveillance population in Bangkok between August 2009 and January 2013.

Authors:  Jens W Levy; Sriluck Simasathien; Veerachai Watanaveeradej; Piraya Bhoomiboonchoo; Stefan Fernandez; Richard G Jarman; Chonticha Klungthong; Robert V Gibbons; Phirangkool Kerdpanich; Danaband Piboonbanakit; Tundorn Chirabandhu; In-Kyu Yoon
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.